Delivery Order SPE2DB20D3103-SPE2DB23FL6D7
Award Date
11/15/22
Potential Completion Date
11/16/22
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,566.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product, with a completion date of February 10, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $8,763.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,632.62 firm fixed price delivery order is for the supply of 4567445213 - MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOVANTIK 12.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $8,061.30 and a performance period ending on March 11, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $5,336.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of January 3, 2024 and a Firm Fixed Price pricing type. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
This federal contract award is for $1,626.60 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,116.80, is for the supply of 4567490665 MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was awarded through open competition. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, a Delivery Order valued at $9,110.52, is for the provision of MOVANTIK 12.5 MG TABLET 30S, a medical product. The contract has an ultimate completion date of May 19, 2023 and uses a Firm Fixed Price pricing type. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, with a ceiling value of $5,397.18, is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2023. The award is not designated under any set-aside program, indicating open competition....
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,510.92, is for the delivery of the pharmaceutical product Movantik 12.5 mg tablet, with an ultimate completion date of April 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...